Gene expression in pulmonary fibrosis

Eileen Hsu, Hidekata Yasuoka, Carol A. Feghali-Bostwick

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Pulmonary fibrosis is a phenotype that results from a variety of conditions and is associated with significant morbidity and mortality. Ongoing research in the field is driven by the need for effective treatments for pulmonary fibrosis. In this review, we highlight mechanisms that regulate gene expression in pulmonary fibrosis at multiple levels. Potential pathogenic mechanisms involve genetic background and transcriptional, posttranscriptional, translational, posttranslational, and epigenetic mechanisms. Pulmonary fibrosis results from abnormal gene expression and regulation that arise from a combination of inherited/acquired genetic alterations and environmental triggers. Collectively, these alterations result in increased expression of extracellular matrix components such as collagen and fibronectin and in the observed fibrosis. Insights gained from mechanisms identified to induce and/or perpetuate fibrosis in the lung will yield new targets for the development of more effective therapies.

Original languageEnglish
Pages (from-to)47-56
Number of pages10
JournalCritical Reviews in Eukaryotic Gene Expression
Volume18
Issue number1
Publication statusPublished - 2008
Externally publishedYes

Fingerprint

Pulmonary Fibrosis
Gene Expression
Fibrosis
Gene Expression Regulation
Fibronectins
Epigenomics
Extracellular Matrix
Collagen
Morbidity
Phenotype
Lung
Mortality
Research
Therapeutics

Keywords

  • Extracellular matrix
  • Gene regulation
  • Interstitial lung disease
  • Lung
  • Systemic sclerosis

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics

Cite this

Hsu, E., Yasuoka, H., & Feghali-Bostwick, C. A. (2008). Gene expression in pulmonary fibrosis. Critical Reviews in Eukaryotic Gene Expression, 18(1), 47-56.

Gene expression in pulmonary fibrosis. / Hsu, Eileen; Yasuoka, Hidekata; Feghali-Bostwick, Carol A.

In: Critical Reviews in Eukaryotic Gene Expression, Vol. 18, No. 1, 2008, p. 47-56.

Research output: Contribution to journalArticle

Hsu, E, Yasuoka, H & Feghali-Bostwick, CA 2008, 'Gene expression in pulmonary fibrosis', Critical Reviews in Eukaryotic Gene Expression, vol. 18, no. 1, pp. 47-56.
Hsu E, Yasuoka H, Feghali-Bostwick CA. Gene expression in pulmonary fibrosis. Critical Reviews in Eukaryotic Gene Expression. 2008;18(1):47-56.
Hsu, Eileen ; Yasuoka, Hidekata ; Feghali-Bostwick, Carol A. / Gene expression in pulmonary fibrosis. In: Critical Reviews in Eukaryotic Gene Expression. 2008 ; Vol. 18, No. 1. pp. 47-56.
@article{d235566507b34fad9ce4c559df48a7f1,
title = "Gene expression in pulmonary fibrosis",
abstract = "Pulmonary fibrosis is a phenotype that results from a variety of conditions and is associated with significant morbidity and mortality. Ongoing research in the field is driven by the need for effective treatments for pulmonary fibrosis. In this review, we highlight mechanisms that regulate gene expression in pulmonary fibrosis at multiple levels. Potential pathogenic mechanisms involve genetic background and transcriptional, posttranscriptional, translational, posttranslational, and epigenetic mechanisms. Pulmonary fibrosis results from abnormal gene expression and regulation that arise from a combination of inherited/acquired genetic alterations and environmental triggers. Collectively, these alterations result in increased expression of extracellular matrix components such as collagen and fibronectin and in the observed fibrosis. Insights gained from mechanisms identified to induce and/or perpetuate fibrosis in the lung will yield new targets for the development of more effective therapies.",
keywords = "Extracellular matrix, Gene regulation, Interstitial lung disease, Lung, Systemic sclerosis",
author = "Eileen Hsu and Hidekata Yasuoka and Feghali-Bostwick, {Carol A.}",
year = "2008",
language = "English",
volume = "18",
pages = "47--56",
journal = "Critical Reviews in Eukaryotic Gene Expression",
issn = "1045-4403",
publisher = "Begell House Inc.",
number = "1",

}

TY - JOUR

T1 - Gene expression in pulmonary fibrosis

AU - Hsu, Eileen

AU - Yasuoka, Hidekata

AU - Feghali-Bostwick, Carol A.

PY - 2008

Y1 - 2008

N2 - Pulmonary fibrosis is a phenotype that results from a variety of conditions and is associated with significant morbidity and mortality. Ongoing research in the field is driven by the need for effective treatments for pulmonary fibrosis. In this review, we highlight mechanisms that regulate gene expression in pulmonary fibrosis at multiple levels. Potential pathogenic mechanisms involve genetic background and transcriptional, posttranscriptional, translational, posttranslational, and epigenetic mechanisms. Pulmonary fibrosis results from abnormal gene expression and regulation that arise from a combination of inherited/acquired genetic alterations and environmental triggers. Collectively, these alterations result in increased expression of extracellular matrix components such as collagen and fibronectin and in the observed fibrosis. Insights gained from mechanisms identified to induce and/or perpetuate fibrosis in the lung will yield new targets for the development of more effective therapies.

AB - Pulmonary fibrosis is a phenotype that results from a variety of conditions and is associated with significant morbidity and mortality. Ongoing research in the field is driven by the need for effective treatments for pulmonary fibrosis. In this review, we highlight mechanisms that regulate gene expression in pulmonary fibrosis at multiple levels. Potential pathogenic mechanisms involve genetic background and transcriptional, posttranscriptional, translational, posttranslational, and epigenetic mechanisms. Pulmonary fibrosis results from abnormal gene expression and regulation that arise from a combination of inherited/acquired genetic alterations and environmental triggers. Collectively, these alterations result in increased expression of extracellular matrix components such as collagen and fibronectin and in the observed fibrosis. Insights gained from mechanisms identified to induce and/or perpetuate fibrosis in the lung will yield new targets for the development of more effective therapies.

KW - Extracellular matrix

KW - Gene regulation

KW - Interstitial lung disease

KW - Lung

KW - Systemic sclerosis

UR - http://www.scopus.com/inward/record.url?scp=37249023873&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37249023873&partnerID=8YFLogxK

M3 - Article

C2 - 18197785

AN - SCOPUS:37249023873

VL - 18

SP - 47

EP - 56

JO - Critical Reviews in Eukaryotic Gene Expression

JF - Critical Reviews in Eukaryotic Gene Expression

SN - 1045-4403

IS - 1

ER -